Synonyms: | |
Status: | Approved (1986) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | A02BA03 |
UNII: | 5QZO15J2Z8 |
InChI Key | XUFQPHANEAPEMJ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C8H15N7O2S3 |
Molecular Weight | 337.46 |
AlogP | -0.77 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 4.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 175.83 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 20.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Histamine H2 receptor antagonist | DailyMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Lyase
|
- | - | - | 126 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | 300 | 18-100 | - | 87 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 87 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 10700 | - | - | 14 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 36200 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Gastroesophageal Reflux | 4 | D005764 | ClinicalTrials |
Stomach Ulcer | 4 | D013276 | ClinicalTrials |
Ulcer | 4 | D014456 | ClinicalTrials |
Gastrointestinal Hemorrhage | 3 | D006471 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Breast Carcinoma In Situ | 2 | D000071960 | ClinicalTrials |
Movement Disorders | 2 | D009069 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Immunoglobulin G4-Related Disease | 2 | D000077733 | ClinicalTrials |
Eosinophilic Esophagitis | 2 | D057765 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Thyroid Neoplasms | 1 | D013964 | ClinicalTrials |
HIV Infections | 1 | D015658 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Fibrosis | 1 | D005355 | ClinicalTrials |
Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Anemia, Hemolytic, Autoimmune | 1 | D000744 | ClinicalTrials |
Psoriasis | 1 | D011565 | ClinicalTrials |
HIV Infections | 1 | D015658 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 4975 |
ChEMBL | CHEMBL902 |
DrugBank | DB00927 |
DrugCentral | 1129 |
EPA CompTox | DTXSID5023039 |
FDA SRS | 5QZO15J2Z8 |
Human Metabolome Database | HMDB0001919 |
Guide to Pharmacology | 7074 |
PharmGKB | PA449586 |
SureChEMBL | SCHEMBL972 |
ZINC | ZINC000001530636 |